|
HTT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.22489862276166E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.84659962268563E-10 |
| Normal-vs-Stage2 |
5.826000E-04 |
| Normal-vs-Stage3 |
1.50111999999147E-05 |
| Normal-vs-Stage4 |
1.7155000000546E-06 |
| Stage1-vs-Stage2 |
6.776800E-01 |
| Stage1-vs-Stage3 |
1.578230E-01 |
| Stage1-vs-Stage4 |
5.857600E-01 |
| Stage2-vs-Stage3 |
6.092400E-01 |
| Stage2-vs-Stage4 |
4.370600E-01 |
| Stage3-vs-Stage4 |
1.191820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33730035326118E-10 |
| Normal-vs-AfricanAmerican |
4.443700E-03 |
| Normal-vs-Asian |
5.39379999997536E-07 |
| Caucasian-vs-AfricanAmerican |
7.595200E-01 |
| Caucasian-vs-Asian |
7.788100E-02 |
| AfricanAmerican-vs-Asian |
1.854610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.47070000306493E-08 |
| Normal-vs-Female |
2.20769957870459E-10 |
| Male-vs-Female |
8.102600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.24730259243711E-11 |
| Normal-vs-Age(41-60Yrs) |
1.12479999980764E-07 |
| Normal-vs-Age(61-80Yrs) |
1.82524999999822E-05 |
| Normal-vs-Age(81-100Yrs) |
9.021800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.624300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.397700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.854000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.336600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.957800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.256800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.441800E-01 |
| Classical-VS-Follicular |
1.68140000034178E-07 |
| Classical-VS-Other |
1.188800E-01 |
| Classical-VS-Normal |
7.39408534400354E-14 |
| Tall-VS-Follicular |
3.602600E-03 |
| Tall-VS-Other |
1.149010E-01 |
| Tall-VS-Normal |
2.12819999999558E-05 |
| Follicular-VS-Other |
8.809400E-01 |
| Follicular-VS-Normal |
1.270580E-01 |
| Other-VS-Normal |
2.821400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60110000035907E-07 |
| Normal-vs-N1 |
3.031000E-04 |
| N0-vs-N1 |
9.415800E-01 |
|
|
